Core Insights - Spartan Capital Securities, LLC successfully completed a $3,788,000 private placement for Lipella Pharmaceuticals Inc. [1] - The proceeds will support Lipella's mission to develop innovative therapies for unmet medical needs and fund general corporate purposes [2] - Spartan Capital's CEO highlighted the strength of Lipella's vision and the firm's commitment to facilitating impactful investment opportunities [3] Company Overview - Lipella Pharmaceuticals is focused on developing groundbreaking clinical therapies aimed at significant medical needs [2] - Spartan Capital Securities is a full-service investment banking firm known for its expertise in capital raising and strategic advisory services [6] Transaction Details - Spartan Capital acted as the sole placement agent for the private offering [1][3] - Legal counsel for the transaction included Sichenzia Ross Ference Carmel LLP for the placement agent and Sullivan & Worcester LLP for Lipella Pharmaceuticals [3] - Further transaction details will be available in Lipella's Form 8-K to be filed with the U.S. Securities and Exchange Commission [4]

Group 1 - Spartan Capital Securities, LLC successfully completed a $3,788,000 private placement for Lipella Pharmaceuticals Inc. [1][2] - The proceeds will support Lipella's mission to develop innovative therapies for unmet medical needs and fund general corporate purposes [2] - Jonathan Kaufman, CEO of Lipella, is focused on advancing the company's clinical pipeline and transformative treatments [2] Group 2 - John Lowry, CEO of Spartan Capital, expressed honor in serving as the sole placement agent and highlighted Lipella's commitment to medical innovation [3] - The transaction reflects the strength of Lipella's vision and Spartan Capital's dedication to impactful investment opportunities [3] - Legal counsel for the transaction included Sichenzia Ross Ference Carmel LLP for the placement agent and Sullivan & Worcester LLP for Lipella [3] Group 3 - Further details on the transaction will be available in Lipella's Form 8-K, to be filed with the U.S. Securities and Exchange Commission [4] - The common shares and related warrants have not been registered under the Securities Act of 1933, limiting their sale until registration or exemption [5] - This press release does not constitute an offer to sell or solicit offers to buy the securities [6]

Core Insights - Spartan Capital Securities, LLC successfully completed a $15.2 million private placement for Healthcare Triangle, Inc. to support its expansion and digital transformation initiatives in the healthcare and life sciences sectors [1][2]. Group 1: Financial Details - The proceeds from the private placement will be utilized for strategic acquisitions, general corporate purposes, and working capital needs, enhancing Healthcare Triangle's mission in cloud enablement, cybersecurity, and data analytics solutions [2]. - Spartan Capital Securities played a significant role by placing $14.2 million of the total private placement, highlighting its strong position in the investment banking sector [2]. Group 2: Company Statements - John Lowry, CEO of Spartan Capital Securities, expressed honor in serving as Co-Placement Agent for Healthcare Triangle, emphasizing the company's leadership in digital innovation within healthcare and life sciences [3]. - The successful transaction reflects both Healthcare Triangle's strong vision and Spartan Capital's commitment to facilitating meaningful investment opportunities [3]. Group 3: Legal and Compliance - The securities involved in the offering, including common stock and various warrants, have not been registered under the Securities Act of 1933 or any state securities laws, and cannot be offered or sold in the U.S. without registration or an applicable exemption [4].

Core Insights - The report titled "Enterprise Tech Ecosystem Series: Goldman Sachs 2024" provides an in-depth analysis of Goldman Sachs' technology activities, focusing on digital transformation strategies, innovation programs, and technology initiatives [1][6]. Company Overview - Goldman Sachs is a multinational financial institution that provides a range of services including investment banking, consumer banking, securities, and investment management to various clients globally [2]. - The company operates through four main business segments: Global Markets, Asset Management, Investment Banking, and Consumer & Wealth Management [2]. Revenue Generation - Global Markets generates revenue through financing and intermediation activities [3]. - Investment Banking focuses on corporate lending, underwriting, and financial advisory services [3]. - Asset Management earns revenue from lending, debt investments, equity investments, incentive fees, and management fees [3]. - Consumer & Wealth Management derives revenue from consumer-oriented activities, private lending, and banking services [3]. Technology Initiatives - The report outlines insights into Goldman Sachs' digital transformation strategies and innovation programs [6]. - It covers technology initiatives including partnerships and product launches, detailing the objectives and benefits of each initiative [6]. - The report also provides an overview of estimated ICT budgets and major ICT contracts [6]. Key Topics Covered - Digital Transformation Strategy - Accelerators, Incubators, and Innovation Programs - Technology Focus and Initiatives - Venture Arm, Investments, and Acquisitions - Partnership, Investment & Acquisition Network Map - ICT Budget and Key Executives [4][6].

Financial Data and Key Metrics Changes - For Q4 2024, the company expects net income available to common shareholders to be between $48 million and $68 million, including approximately $236 million to $247 million from discontinued operations related to the divestiture of Great American businesses [30][31] - Diluted net income per share is projected to be between $1.57 and $2.22, with a net loss from continuing operations estimated at $178 million to $187 million, primarily due to impairment charges and trading losses [31][32] - Operating adjusted EBITDA from continuing operations is expected to be between $12 million and $14 million, with total debt reported at $1.78 billion, a decline of $221 million from the previous quarter [32][33] Business Line Data and Key Metrics Changes - The company established a joint venture with Oaktree Capital Management, contributing its appraisal and valuation services, which resulted in approximately $203 million in cash and a 44% ownership interest in the new entity [9][10] - The Wealth Management business is expected to manage approximately $15 billion in client assets after the sale of a portion of its traditional W-2 business to Stifel Financial Corp [12][23] - GlassRatner, the advisory services business, had a record year in 2024, indicating strong performance in its core expertise areas [24][42] Market Data and Key Metrics Changes - The company reported a strong December for its broker-dealer segment, which is positioned as a top provider to the middle market segment, with expectations of substantial operating EBITDA in a normalized environment [20][21] - The telecom business continues to provide steady cash flow and EBITDA, contributing positively to the overall financial health of the company [46] Company Strategy and Development Direction - The company aims to focus on its core businesses, including B. Riley Securities, Wealth Management, and advisory services, while monetizing non-core assets to strengthen its balance sheet [17][16] - The strategic partnership with Oaktree is expected to enhance the company's ability to deliver financial products and services, leveraging Oaktree's expertise and scale [10][11] - The company plans to continue exploring strategic opportunities to unlock value within its core business segments [22][42] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about emerging from a period of asset monetization and debt reduction, positioning the company as a more nimble and focused entity [17][66] - The management acknowledged the challenges faced due to principal investments but emphasized the potential for recovery and growth in core operations [27][66] - The company is committed to investing in its business and addressing outstanding debt maturities while limiting dilution for shareholders [36][38] Other Important Information - The company completed the full redemption of its February 2025 senior notes, retiring its only significant maturity for that year [14] - A new $160 million senior secured credit facility was established with Oaktree, providing greater financial flexibility [15] Q&A Session Summary Question: What are the plans for liquidity and balance sheet improvement in the next six months? - Management indicated a focus on investing in core businesses and proactively aligning the balance sheet, with ongoing asset monetization efforts [36][37] Question: Can you provide insights on the core business's EBITDA and cash flow potential? - Management highlighted the historical performance of core businesses and expressed confidence in their ability to generate operating EBITDA, despite recent challenges [38][42] Question: What is the current state of the Wealth Management business after the recent sale? - The remaining Wealth Management group now manages approximately $15 billion in assets, down from $24 billion prior to the sale [58] Question: Will future asset monetization primarily come from the Principal Investment Group? - Management confirmed a careful approach to monetizing non-core assets while focusing on growing core businesses [60][61]

Summary of Key Points from the Conference Call Industry and Company Overview - The conference call focuses on the **US Dollar (USD)** and its expected performance in **2025**, drawing parallels with **2017** and **2018**. The analysis is provided by **Morgan Stanley Research**. Core Insights and Arguments 1. **USD Decline in 2017**: The USD declined in 2017 due to trade policy, global growth, and European politics, with fiscal and Fed policy being less supportive than anticipated. Similar factors are expected to contribute to a decline in 2025 [1][4][68]. 2. **Trade Policy**: In 2025, the USD is expected to be negatively impacted by trade policy, similar to 2017. The administration is likely to use tariffs as a negotiation tactic, particularly with China, Canada, and Mexico [77][78][80]. 3. **Fiscal Policy**: The fiscal policy is not expected to be fully incorporated into growth expectations until a budget reconciliation bill is passed. This mirrors the situation in 2017, where deficit forecasts remained unchanged until late in the year [4][68][106]. 4. **Global Growth Expectations**: Global growth in 2025 is anticipated to align with expectations, contrasting with the faster-than-expected growth in 2017. This is expected to have a neutral or slightly negative impact on the USD [4][113]. 5. **European Politics**: Political stability in Europe is expected to improve, reducing EUR-negative risk premiums, similar to the underperformance of EU-skeptical parties in 2017 [4][69][117]. 6. **Central Bank Policies**: The Fed is expected to cut rates, while the ECB's policies may lead to a stronger EUR against the USD. This reflects the changes in central bank policies observed in 2017 [4][119][125]. Additional Important Insights 1. **Tariff Expectations**: The expectation of gradual increases in tariffs on imports from China and the Euro Area is highlighted, with a focus on the potential impact on the USD [78][99][103]. 2. **Investor Sentiment**: There is a significant divergence in investor expectations regarding trade policy, with many believing that tariffs will not escalate as much as previously anticipated [91][92]. 3. **Deficit Forecasts**: The analysis indicates that deficit expectations have widened significantly since the 2024 election, similar to the dynamics observed in 2016-2017 [108][109]. 4. **Market Positioning**: The USD has recently declined due to positioning by investors who expected more aggressive tariff measures than those announced [87][88]. This summary encapsulates the key points discussed in the conference call, providing a comprehensive overview of the expected trends in the USD and the influencing factors.

Company Overview - Mobile-health Network Solutions (MNDR) is a pioneering MedTech company focused on enhancing human connection through technology [1] - The company is ranked 41 in the Financial Times 2024 listing of 500 High-growth Asia-Pacific Companies and is the first telehealth provider from the Asia-Pacific region to be listed in the US [4] - MNDR offers a range of telehealth solutions including teleconsultation services, prescription fulfillment, and personalized services such as weight management programs and gender-specific care [4] Upcoming Events - MNDR will present at the Centurion One Capital 8th Annual Growth Conference from March 3rd to March 6th, 2025, at the Four Seasons Hotel in Toronto [1][3] - Co-founders and co-CEOs, Dr. Tung Yeng Siaw and Dr. Rachel Teoh, are scheduled to present on March 6th, 2025, focusing on the company's latest AI technology innovations [2] - The presentation will include the newly deployed AI Agent platform aimed at improving healthcare providers' workflow efficiency [2] Industry Context - The telehealth solutions industry is experiencing growth, with MNDR positioned to capitalize on this trend through its innovative technology and services [4] - Centurion One Capital, the investment banking firm hosting the conference, is dedicated to supporting the growth of companies in North America, indicating a favorable environment for investment in the sector [5][6]

投行成长学习包 学习包内容 1.纸质资料《投行成长笔记》 2.线上课程《如何评估企业上市可行性》 3.梧桐定制笔记本1个 在外人看来，投行是一个非常令人向往的行业。然而，只有真正在投行里爬摸滚打过的人才知道，干投 行其实是件苦力活， 不仅压力大、强度大、挑战大，而且需要法律、财务、业务全方位发展，非常不容 易。 特别对于投行新人来说，如果没有靠谱的前辈领路，很难快速找到适合自己的成长路径，基本要在繁琐 的基础工作中耗费几年光阴。 为了帮助投行新人或者想要进入投行的其他人士详细了解投行的工作内容、知识框架、专业技能等，我 们 上线了 —— 《投行成长笔记》共有312页、12多万字、9个章节。 投行成长学习包 扫码购买限时 7.7折 内容很实在，既介绍了 投行的职业规划和行业情况， 也讲解了 行研、尽调、财务、估值、承揽 等投行 人必备的工作技能，此外，还针对IPO业务，补充了 当前上市审核的关注重点和企业各部门在IPO中的 工作安排。 ▼下滑查看《投行成长笔记》目录▼ ▲点击图片可放大▲ 第一、二章主要介绍了我们入职投行前需要知道的基本事项，包括投行具体部门的划分、监管法规体 系、职业基本技能、具体项目分类、日 ...

文/梧桐数据中心 2024年，港股新上市公司累计70家，其中主板67家，创业板3家，数量与2023年持平，募集资金金额合计873.18亿港元，同比增长89.93%。中介机构业绩方面，中 金公司保荐19单，位列第一；中信证券12单、华泰国际7单，位列二三；高伟绅律师行和竞天公诚律所分别占据香港、中国法律顾问之首，业务单数分别为12单、 13单；"四大"则包揽了近90%的审计业务，毕马威19单，罗兵咸永道18单、安永15单、德勤12单。 一、保荐人业绩排名 2024年，共有39家保荐人为这70家香港上市公司提供了保荐服务，其中联合保荐的拆开计算，各计1单。 第一名：中金公司（19单） 第二名：中信证券（香港）（12单） 第三名：华泰国际（7单） | 1 | 甲金公可 | । તે | | --- | --- | --- | | 2 | 中信证券(香港) | 12 | | 3 | 八年泰国际 | 7 | | 4. | 海通国际 | 6 | | 5 | 建银国际 | 5 | | 5 | 招银国际 | 5 | | 7 | 摩根大通 | 4 | | 7 | 衣银国际 | 4 | | 7 | 瑞银集团 | 4 | | 10 ...

周年庆充值活动最后1天 12月2~5日 充值 ¥1000 再送 ￥120 充1000送120 充500送50 充2000送260 充3000送400 充10000送2000 充5000送700 生存在 补贴价购买 1V1课程顾问 补贴价报名 纸质阅读材料 线下培训 解决学习问题 2024年上新课程一览 | 课程名称 | 价格 | | --- | --- | | 2024年"境内上市"新课 | | | 国九条对IPO工作的影响 | 88 | | 《证券法》系列课 | 299 | | 北交所上市全解析专题 | 399 | | 拟IPO企业财务规范流程及策略（2024年） | 199 | | 不同板块IPO审核要点解析 (14案例) | 88 | | 2024年"境外上市"新课 | | | 境内企业赴美国上市的法律实务解读 | 199 | | 资本市场以及企业出海的核心税务考量 | 399 | | 境外投资并购法律实务 | 499 | | 企业出海：跨境业务股权设计与效能考量 | 128 | | 人 そ 二十二十六 二十二十二十二 | AAA | | 海外投融资申批头务 | 299 | | --- | --- | ...